Giulia De Sabbata, PhDDirector and Head of Discovery at VectorY TherapeuticsSpeaker
Agenda Sessions
AAV-mediated Delivery of an Intrabody Targeting TDP-43 for Amyotrophic Lateral Sclerosis Therapy
, 2:30pmView Session
